Mitochondrial abnormalities in CLN2 and CLN3 forms of Batten disease

Molecular and Chemical Neuropathology
G DawsonI Singh

Abstract

The storage of subunit c of mitochondrial ATP synthase, other hydrophobic peptides, and autofluorescent pigment in both late infantile (CLN2) and juvenile (CLN3) neuronal ceroid lipofuscinosis, but not in infantile (CLN1), has raised the question of abnormal mitochondrial function. We now report a partial deficiency in three types of fatty acid oxidation in intact skin fibroblasts from CLN2 and CLN3 patients, but not CLN1. We observed a statistically significant 33% reduction in palmitate (beta-oxidation; mainly mitochondrial) and lignocerate (beta-oxidation; mainly peroxisomal), and a 50% reduction in phytanic acid (alpha-oxidation; mainly peroxisomal) in the absence of exogenous carnitine. In contrast, when we measured fatty acid beta-oxidation (lignoceric acid and palmitic acid), in the same human skin fibroblasts, following lysis in the presence of carnitine, we found no difference in enzyme activity among normal, CLN1, CLN2, and CLN3. However, we did observe a 40% reduction in peroxisomal particulate (bound) catalase activity in CLN1 and CLN2 fibroblasts, which typically results from organellar lipid accumulation or a membrane abnormality. However, total catalase levels were normal, and Western blot analysis of this and th...Continue Reading

References

Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·H TowbinJ Gordon
Feb 15, 1992·American Journal of Medical Genetics·D N PalmerR D Jolly
Feb 15, 1992·American Journal of Medical Genetics·J A RiderA N Siakotos
Aug 31, 1987·Biochemical and Biophysical Research Communications·G Dawson, P Glaser
Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·I SinghH W Moser
Jun 5, 1995·American Journal of Medical Genetics·M L Katz, A N Siakotos
Jan 1, 1993·Journal of Inherited Metabolic Disease·G DawsonA N Siakotos

❮ Previous
Next ❯

Citations

Feb 19, 2002·Neurochemistry International·R D JollyS U Walkley
Oct 15, 2013·British Journal of Pharmacology·L D Osellame, M R Duchen
Feb 4, 2006·Neurobiology of Aging·Sabrina S Seehafer, David A Pearce
Oct 20, 2006·Biochimica Et Biophysica Acta·Judith A Hobert, Glyn Dawson
Oct 20, 2006·Biochimica Et Biophysica Acta·Seasson N PhillipsDavid A Pearce
Aug 31, 2006·Journal of Neuroscience Research·Kaisu LuiroAnu Jalanko
Feb 1, 1997·Journal of Advanced Nursing·R Kolcaba
Jan 27, 2005·Journal of Neuroscience Research·Morwenna Y PorterSara E Mole
Oct 28, 2019·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Christopher J MinnisTristan R McKay
Nov 4, 2020·International Journal of Molecular Sciences·Elena K Shematorova, George V Shpakovski
Aug 17, 2021·Frontiers in Genetics·Yesid Cuesta-AstrozAlberto J M Martin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Batten Disease

Batten Disease is a group of nervous system disorders known as neuronal ceroid lipofuscinosis. This feed focuses on neurobiological and neuropathological aspects of this disease.